Startle Testing with MDMA Timeline

Startle Testing with MDMA: Thirty-First Participant Receives Experimental Treatment

On March 25, 2020, the thirty-first participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. Enrollment to this study is currently on hold due to COVID-19. • Learn More

Startle Testing with MDMA: Twenty-Eighth Participant Receives Experimental Treatment

On February 19, 2020, the twenty-eighth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. If you have tried MDMA, you may be eligible to enroll in this study investigating the effects of MDMA on the startle response. You will receive monetary compensation for completing the study. All involvement is confidential. This study takes place at Emory University in Atlanta, Georgia. For more information, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.. • Learn More

Startle Testing with MDMA: Twenty-Ninth Participant Receives Experimental Treatment

On March 11, 2020, the twenty-ninth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. • Learn More

Startle Testing with MDMA: Recruiting Volunteers

Our ongoing study of the effect of MDMA on startle testing is recruiting healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. If you have tried MDMA, you may be eligible to enroll in this study investigating the effects of MDMA on the startle response. You will receive monetary compensation for completing the study. All involvement is confidential. This study takes place at Emory University in Atlanta, Georgia. For more information, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.. • Learn More

Startle Testing with MDMA: Twenty-Fourth Participant Receives Experimental Treatment

On December 18, 2019, the twenty-fourth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. If you have tried MDMA, you may be eligible to enroll in this study investigating the effects of MDMA on the startle response. You will receive monetary compensation for completing the study. All involvement is confidential. This study takes place at Emory University in Atlanta, Georgia. For more information, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.. Learn More

Startle Testing with MDMA: Twenty-Third Participant Receives Experimental Treatment

On November 14, 2019, the twenty-third participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia.

If you have tried MDMA, you may be eligible to enroll in this study investigating the effects of MDMA on the startle response. You will receive monetary compensation for completing the study. All involvement is confidential. This study takes place at Emory University in Atlanta, Georgia. For more information, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.. • Learn More

Startle Testing with MDMA: Seeking Study Participants

If you have tried MDMA, you may be eligible to enroll in this study investigating the effects of MDMA on the startle response. You will receive monetary compensation for completing the study. All involvement is confidential. This study takes place at Emory University in Atlanta, Georgia. For more information, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.. • Learn More

Startle Testing with MDMA: Twentieth Participant Receives Experimental Treatment

On September 18, 2019, the twentieth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. If you have tried MDMA, you may be eligible to enroll in this study investigating the effects of MDMA on the startle response. For more information, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.. • Learn More

Startle Testing with MDMA: Nineteenth Participant Receives Experimental Treatment

On August 28, 2019, the nineteenth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. • Learn More

Startle Testing with MDMA: Seventeeth Participant Receives Experimental Treatment

On July 15, 2019, the seventeenth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. • Learn More

Startle Testing with MDMA: Fifteenth Participant Receives Experimental Treatment

On June 5, 2019, the fifteenth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. This research group is planning to conduct a subsequent study exploring the combination of MDMA with Prolonged Exposure in people with PTSD. • Learn More

Startle Testing with MDMA: Thirteenth Participant Receives Experimental Treatment

On May 1, 2019, the thirteenth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. This research group is planning to conduct a subsequent study exploring the combination of MDMA with Prolonged Exposure in people with PTSD. • Learn More

Startle Testing with MDMA: Twelfth Participant Receives Experimental Treatment

On March 6, 2019, the twelfth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. This research group is planning to conduct a subsequent study exploring the combination of MDMA with Prolonged Exposure in people with PTSD. • Learn More

Startle Testing with MDMA: Fourteenth Participant Receives Experimental Treatment

On February 20, 2019, the fourteenth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. This research group is planning to conduct a subsequent study exploring the combination of MDMA with Prolonged Exposure in people with PTSD. • Learn More

Startle Testing with MDMA: Ninth Participant Receives Experimental Treatment

On October 17, 2018, the ninth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. This research group is planning to conduct a subsequent study exploring the combination of MDMA with Prolonged Exposure in people with PTSD. Learn more...

Startle Testing with MDMA: Eighth Participant Receives Experimental Treatment

On August 27, 2018, the eighth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. This study will be followed by another study exploring the combination of MDMA with Prolonged Exposure in PTSD patients. Learn more...

Startle Testing with MDMA: Seventh Participant Receives Experimental Treatment

On August 24, 2018, the seventh participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. This study will be followed by another study exploring the combination of MDMA with Prolonged Exposure in PTSD patients. Learn more...

Startle Testing with MDMA: Recruitment Update

On November 9, 2017, the Institutional Review Board approved the study protocol for the effect of MDMA on startle testing in healthy volunteers. This MAPS-sponsored study will be conducted by Principal Investigator Barbara Rothbaum, Ph.D., at Emory University in Atlanta, Georgia. Local recruitment via phone screening began on December 13, 2017. In-person screening will begin January 2018. This study will be followed by another study exploring the combination of MDMA with Prolonged Exposure in PTSD patients.
Learn more...

Startle Testing with MDMA: Recruitment Update

As of February 15, 2018, a total of 23 people have completed preliminary phone screening for enrollment opportunities in our study of the effect of MDMA on startle testing in healthy volunteers conducted by Principal Investigator Barbara Rothbaum, Ph.D., at Emory University in Atlanta, Georgia. In-person screening will begin March 2018 with enrollment to follow. This study will be followed by another study exploring the combination of MDMA with Prolonged Exposure in PTSD patients.
Learn more...

Startle Testing with MDMA: First Participant Receives Experimental Treatment

On March, 15, 2018, the first participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. As of March 19, 2018, a total of 43 people have completed preliminary phone screening for enrollment opportunities. This study will be followed by another study exploring the combination of MDMA with Prolonged Exposure in PTSD patients.
Learn more...

Startle Testing with MDMA: Institutional Review Board Approves First Protocol Amendment

On January 3, 2017, the Institutional Review Board (IRB) at Emory University approved the first protocol amendment for our upcoming Phase 1 study on the effect of MDMA on startle testing in healthy volunteers. Principal Investigator Barbara Rothbaum, Ph.D., a leading PTSD researcher, will conduct the study at Emory University in Atlanta, Georgia. The required safe for the study drug is installed, and we are ready for inspection by the Drug Enforcement Administration (DEA). The study will begin after DEA approval. Learn more...

Startle Testing with MDMA: FDA Clears Study to Proceed

On November 30, 2016, the FDA cleared the upcoming MAPS-sponsored Phase 1 study on the effect of MDMA on startle testing in healthy volunteers. Principal Investigator Barbara Rothbaum, Ph.D., a leading PTSD researcher, will conduct the study at Emory University in Atlanta, Georgia. The original protocol was approved by the Institutional Review Board (IRB) on July 26, 2016. The DEA is currently reviewing the protocol, with the study expected to begin in 2017.